...Operator Good afternoon and thank you all for joining us. We are very pleased to announce positive top line results from the Phase 2 HELIOS clinical trial of AMX35 in wolfram syndrome. Before we begin, I'd like to point out that we will be making forward-looking statements today, which are based on our current expectations and beliefs. We have a number of important disclosures on this slide which I urge you to read. Touching briefly on today's agenda, Dr. Camille Bedrosian, our Chief Medical Officer, will share an overview of wolfram syndrome and will review the data generated from the HELIOS clinical trial to date as well as discuss next steps for the program. We're also thrilled to have Dr. Fumihiko Urano, join us today. Doctor Urano is the Principal Investigator of HELIOS and the Samuel E. Schechter, Professor of Medicine at Washington University School of Medicine in Saint Louis. Also joining us for Q&A are Joshua Cohen and Justin Klee, our co-CEOs; and Jim Frates, our Chief Financial...
